ATRA logo

Atara Biotherapeutics (ATRA)

Profile

Full Name

Atara Biotherapeutics, Inc.

Ticker Symbol

ATRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 16, 2014

Indexes

Not included

Website

http://www.atarabio.com

Employees

153

Key Details

Price

$5.84(-2.34%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$128.94M(+1404.02% YoY)

Annual EPS

-$11.41(+82.50% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.84
ATRA price is $5.84

30-Day Relative Volume

1.55
ATRA 30-day relative volume is 1.55

Price Performance

Price Most recent change

-2.34%
ATRA price was down -2.34% on Apr 16, 2025

Price YTD change

-56.12%
ATRA price is down -56.12% since January 1st

Price 1-year change

-67.33%
ATRA price is down -67.33% year-on-year

Price 3-year change

-97.08%
ATRA price is down -97.08% over the past 3 years

Price Range

Price All-time high

$1600.50
ATRA price is currently -99.64% below its historical high of $1600.50

Price 3-year low

$0.20
ATRA price is currently +2834.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$34.22M
ATRA market capitalization is $34.22 million

Market cap 3-year change

-95.43%
ATRA market capitalization is down -95.43% over the past 3 years

Market cap All-time high

$2.26B
ATRA market capitalization is currently -98.49% below its historical high of $2.26 billion

Market cap sector rank

32.81%
ATRA market capitalization is higher than 32.81% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+21.73%
ATRA shares outstanding is up +21.73% year-on-year

Shares Outstanding 3-Year Change

+56.81%
ATRA shares outstanding is up +56.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.42
ATRA beta is 1.42

200-day SMA

$9.08
ATRA price is currently -35.67% below its 200-day simple moving average

50-day SMA

$7.05
ATRA price is currently -17.17% below its 50-day simple moving average

RSI

42.96
ATRA 14-day relative strength index is 42.96

Volume

1.55
ATRA 30-day relative volume is 1.55

ATR

$0.56
ATRA average true range is $0.56

10-day Historical Volatility

82.95%
ATRA 10-day historical volatility is 82.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$128.94M
ATRA annual revenue is $128.94 million

Revenue Analysts estimate

$41.87M
ATRA annual revenue is currently +207.96% higher than the consensus analysts' forecast

Revenue 1-year change

+1404.02%
ATRA annual revenue is up +1404.02% year-on-year

Revenue Sector rank

58.9%
ATRA annual revenue is higher than 58.9% of companies in Healthcare sector

EPS

EPS

-$11.41
ATRA annual earnings per share is -$11.41

EPS Analysts estimate

-$5.80
ATRA annual earnings per share is currently +96.55% higher than the consensus analysts' forecast

EPS 1-year change

+82.5%
ATRA annual earnings per share is up +82.5% year-on-year

EPS Sector rank

10.83%
ATRA annual earnings per share is higher than 10.83% of companies in Healthcare sector

Profit

Gross profit

$107.93M
ATRA annual gross profit is $107.93 million

Gross margin

83.71%
ATRA annual gross profit margin is 83.71%

Operating profit

-$83.44M
ATRA annual operating income is -$83.44 million

Operating margin

-64.71%
ATRA annual operating profit margin is -64.71%

Net income

-$85.40M
ATRA annual net profit is -$85.40 million

Net margin

-66.23%
ATRA annual net profit margin is -66.23%

Expenses

Total expenses

$212.38M
ATRA annual total expenses is $212.38 million

Operating expenses

$191.37M
ATRA annual total operating expenses is $191.37 million

Cost of goods sold

$21.01M
ATRA annual cost of goods sold is $21.01 million

Selling, general & administrative expenses

$39.89M
ATRA annual SGA is $39.89 million

Depreciation and amortization

$5.05M
ATRA annual depreciation & amortization is $5.05 million

Interest expense

$4.62M
ATRA annual interest expense is $4.62 million

Income tax

-$12.00K
ATRA annual income tax is -$12.00 thousand

EBIT & EBITDA

EBIT

-$80.80M
ATRA annual earnings before interest & taxes is -$80.80 million

EBITDA

-$75.75M
ATRA annual EBITDA is -$75.75 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$109.10M
ATRA annual total assets is $109.10 million

Non current assets

$44.20M
ATRA annual long term assets is $44.20 million

Current assets

$64.89M
ATRA annual total current assets is $64.89 million

Cash and cash equivalents

$25.03M
ATRA annual cash & cash equivalents is $25.03 million

Accounts receivable

$1.48M
ATRA annual accounts receivable is $1.48 million

Inventory

$10.65M
ATRA annual inventory is $10.65 million

Liabilities

Total liabilities

$206.38M
ATRA annual total liabilities is $206.38 million

Long term liabilities

$71.81M
ATRA annual total long term liabilities is $71.81 million

Current liabilities

$134.57M
ATRA annual total current liabilities is $134.57 million

Accounts payable

$4.37M
ATRA annual accounts payable is $4.37 million

Debt

Total debt

$43.83M
ATRA annual total debt is $43.83 million

Total debt 1-year change

-24.26%
ATRA annual total debt is down -24.26% year-on-year

Long term debt

$29.91M
ATRA annual long term debt is $29.91 million

Short term debt

$13.92M
ATRA annual short term debt is $13.92 million

Equity & Capital

Shareholders equity

-$97.28M
ATRA annual stockholders equity is -$97.28 million

Book value

-$97.28M
ATRA annual book value is -$97.28 million

Retained earnings

-$2.05B
ATRA annual retained earnings is -$2.05 billion

Working capital

-$69.68M
ATRA annual working capital is -$69.68 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$68.72M
ATRA annual cash flow from operations is -$68.72 million

Cash from operations 1-year change

+64.39%
ATRA annual cash flow from operations is up +64.39% year-on-year

Cash from investing

$8.62M
ATRA annual cash flow from investing activities is $8.62 million

Cash from investing 1-year change

-93.04%
ATRA annual cash flow from investing activities is down -93.04% year-on-year

Cash from financing

$59.28M
ATRA annual cash flow from financing activities is $59.28 million

Cash from financing 1-year change

+2849.35%
ATRA annual cash flow from financing activities is up +2849.35% year-on-year

CAPEX

CAPEX

$246.00K
ATRA annual capital expenditures is $246.00 thousand

CAPEX 1-year change

-79.89%
ATRA annual capital expenditures is down -79.89% year-on-year

Free Cash Flow

Free cash flow

-$68.96M
ATRA annual free cash flow is -$68.96 million

Free cash flow 1-year change

+64.49%
ATRA annual free cash flow is up +64.49% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

83.71%
ATRA annual gross profit margin is 83.71%

Operating margin

-64.71%
ATRA annual operating profit margin is -64.71%

Net margin

-66.23%
ATRA annual net profit margin is -66.23%

ROA & ROE

ROA

-62.20%
ATRA annual return on assets is -62.20%

ROE

87.79%
ATRA annual return on equity is 87.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ATRA price to earnings ratio value is unknown

PE ratio Sector rank

-
ATRA price to earnings ratio is unknown

PB Ratio

PB ratio

-0.35
ATRA price to book ratio is -0.35

PB ratio Sector rank

10.96%
ATRA price to book ratio is higher than 10.96% of companies in Healthcare sector

PS Ratio

PS ratio

0.27
ATRA price to sales ratio is 0.27

PS ratio Sector rank

10%
ATRA price to sales ratio is higher than 10% of companies in Healthcare sector

Enterprise value

Enterprise value

$53.02M
ATRA enterprise value is $53.02 million

Enterprise value Sector rank

42.28%
ATRA enterprise value is higher than 42.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.70
ATRA EV/EBITDA is -0.70

EV/EBITDA Sector rank

47.74%
ATRA EV/EBITDA is higher than 47.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.48
ATRA annual current ratio is 0.48

Quick ratio

0.40
ATRA annual quick ratio is 0.40

Leverage

Debt to equity

0.00
ATRA annual debt to equity ratio is 0.00

Interest coverage ratio

-17.51
ATRA annual interest coverage ratio is -17.51

Risk & Stability

Piotroski F-Score

4
ATRA piotroski f-score is 4

Altman Z-Score

-28.29
ATRA altman z-score is -28.29

Analyst ratings

Recent major analysts updates

Mar 11, 25 Canaccord Genuity
Buy
Jan 22, 25 HC Wainwright & Co.
Neutral
Jan 17, 25 Canaccord Genuity
Buy
Dec 20, 24 Rodman & Renshaw
Buy
Nov 13, 24 Canaccord Genuity
Buy
Aug 21, 24 HC Wainwright & Co.
Neutral
Aug 16, 24 Mizuho
Outperform
Aug 13, 24 Canaccord Genuity
Buy
Jul 17, 24 Goldman Sachs
Sell
May 22, 24 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

ME logo
23andMe Holding Co (ME)
OS Therapies Incorporated (OSTX)
XFOR logo
X4 Pharmaceuticals (XFOR)
SHLT logo
SHL Telemedicine (SHLT)
Opus Genetics (IRD)
MODD logo
Modular Medical (MODD)
RMTI logo
Rockwell Medical (RMTI)
APYX logo
Apyx Medical (APYX)
RVPH logo
Reviva Pharmaceuticals Holdings (RVPH)
  • What is the ticker symbol for Atara Biotherapeutics?
  • Does Atara Biotherapeutics pay dividends?
  • What sector is Atara Biotherapeutics in?
  • What industry is Atara Biotherapeutics in?
  • What country is Atara Biotherapeutics based in?
  • When did Atara Biotherapeutics go public?
  • Is Atara Biotherapeutics in the S&P 500?
  • Is Atara Biotherapeutics in the NASDAQ 100?
  • Is Atara Biotherapeutics in the Dow Jones?
  • When was Atara Biotherapeutics's last earnings report?
  • When does Atara Biotherapeutics report earnings?
  • Should I buy Atara Biotherapeutics stock now?

What is the ticker symbol for Atara Biotherapeutics?

The ticker symbol for Atara Biotherapeutics is NASDAQ:ATRA

Does Atara Biotherapeutics pay dividends?

No, Atara Biotherapeutics does not pay dividends

What sector is Atara Biotherapeutics in?

Atara Biotherapeutics is in the Healthcare sector

What industry is Atara Biotherapeutics in?

Atara Biotherapeutics is in the Biotechnology industry

What country is Atara Biotherapeutics based in?

Atara Biotherapeutics is headquartered in United States

When did Atara Biotherapeutics go public?

Atara Biotherapeutics's initial public offering (IPO) was on October 16, 2014

Is Atara Biotherapeutics in the S&P 500?

No, Atara Biotherapeutics is not included in the S&P 500 index

Is Atara Biotherapeutics in the NASDAQ 100?

No, Atara Biotherapeutics is not included in the NASDAQ 100 index

Is Atara Biotherapeutics in the Dow Jones?

No, Atara Biotherapeutics is not included in the Dow Jones index

When was Atara Biotherapeutics's last earnings report?

Atara Biotherapeutics's most recent earnings report was on Mar 7, 2025

When does Atara Biotherapeutics report earnings?

The next expected earnings date for Atara Biotherapeutics is May 9, 2025

Should I buy Atara Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page